
|Articles|August 10, 2017
ARG Forms Rare Disease Advisory Board
Advertisement
Atlantic Research Group, Inc. (ARG)-a rare disease-focused contract research organization (CRO)-announced that it formed its rare disease strategic advisory board (SAB). The SAB will consist of outside scientific experts, patient advocates, and former executives from rare disease-focused biotechs.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Utilizing Tech Tools to Accelerate Drug Development
3
Streamlining Clinical Data to Reduce Site and Participant Burden
4






.png)



.png)



.png)
.png)
